Cargando…
Early Implementation of THAM for ICP Control: Therapeutic Hypothermia Avoidance and Reduction in Hypertonics/Hyperosmotics
Background. Tromethamine (THAM) has been demonstrated to reduce intracranial pressure (ICP). Early consideration for THAM may reduce the need for other measures for ICP control. Objective. To describe 4 cases of early THAM therapy for ICP control and highlight the potential to avoid TH and paralytic...
Autores principales: | Zeiler, F. A., Gillman, L. M., Teitelbaum, J., West, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273533/ https://www.ncbi.nlm.nih.gov/pubmed/25544901 http://dx.doi.org/10.1155/2014/139342 |
Ejemplares similares
-
Antibacterial Activity of THAM Trisphenylguanide against Methicillin-Resistant Staphylococcus aureus
por: Weaver, Alan J., et al.
Publicado: (2014) -
Clinical manifestations and genetic analysis of a newborn with Arboleda−Tham syndrome
por: Zeng, Feng, et al.
Publicado: (2022) -
Diagnosis of Arboleda-Tham syndrome by whole genome sequencing in an Asian boy with severe developmental delay
por: Lin, Yung-Feng, et al.
Publicado: (2020) -
Response to Hyperosmotic Stress
por: Saito, Haruo, et al.
Publicado: (2012) -
KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster
por: Singh, Meghna, et al.
Publicado: (2023)